Giulio Stefanini (@ggstefanini) 's Twitter Profile
Giulio Stefanini

@ggstefanini

Cardiologist | MD, PhD, MSc

ID: 1168483218158424064

linkhttps://scholar.google.com/citations?user=t1KBgJYAAAAJ&hl=en calendar_today02-09-2019 11:18:13

263 Tweet

911 Followers

135 Following

Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

The 2023 ESC guidelines for the management of acute coronary syndromes are online, for the first time reporting in the same document the recommendations for STEMI, NSTE-ACS and unstable angina. #ESCCongress academic.oup.com/eurheartj/adva…

The 2023 ESC guidelines for the management of acute coronary syndromes are online, for the first time reporting in the same document the recommendations for STEMI, NSTE-ACS and unstable angina. #ESCCongress academic.oup.com/eurheartj/adva…
chief (@alaide_chief) 's Twitter Profile Photo

🔝🔝🔝Session at #PCRLV On #challenges in #TAVI ⭐️how to manage CAD and AS ⭐️tip & trick on how to reaccess coronaries after TAVI ⭐️how to manage VHD in CS ⭐️come to #EAPCI booth and beacons #EAPCI member

🔝🔝🔝Session at #PCRLV 
On #challenges in #TAVI 
⭐️how to manage CAD and AS
⭐️tip & trick on how to reaccess coronaries after TAVI 
⭐️how to manage VHD in CS 
⭐️come to #EAPCI booth and beacons #EAPCI member
European Society of Cardiology (@escardio) 's Twitter Profile Photo

As medical practitioners, you want access to safe and innovative medical devices that will impact your patient's care. But the medical device regulatory world is a complex and often makes access to new devices slow. We need to change that. #ESCardioCRT this week will be delving

As medical practitioners, you want access to safe and innovative medical devices that will impact your patient's care. But the medical device regulatory world is a complex and often makes access to new devices slow. We need to change that.

#ESCardioCRT this week will be delving
European Society of Cardiology (@escardio) 's Twitter Profile Photo

Get the wrap-up of #ESCardioCRT day one from Giulio Stefanini with a particular focus on why #MedicalDevices regulatory assessment throughout their entire lifecycle assures #PatientSafety 👇 #MDR #patientcare

chief (@alaide_chief) 's Twitter Profile Photo

First-ever open call to ALL #EAPCI Members for positions on the upcoming #EAPCI Committees 2024- 2026 APPLY NOW to shape the future of #IC and #EAPCI: 🔗bit.ly/EAPCIcall 🫵YOU ARE #EAPCI🫵

Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

Evidence for short DAPT after an ACS in high bleeding risk patients undergoing PCI is limited. In this study, high bleeding risk patients undergoing non-complex PCI for either NSTE-ACS or chronic coronary syndrome experienced similar ischemic risk and reduced bleeding with

Evidence for short DAPT after an ACS in high bleeding risk patients undergoing PCI is limited. 

In this study, high bleeding risk patients undergoing non-complex PCI for either NSTE-ACS or chronic coronary syndrome experienced similar ischemic risk and reduced bleeding with
EAPCIPresident (@eapcipresident) 's Twitter Profile Photo

The #EAPCI Core Curriculum for Percutaneous Valvular & Structural Heart Intervention Published in EuroIntervention on the occasion of #ESCCongress 2024 Significant work from the #EAPCI Training & Certification Committee and collaborators. bit.ly/3XowWGh

The #EAPCI Core Curriculum for Percutaneous Valvular & Structural Heart Intervention

Published in <a href="/EuroInterventio/">EuroIntervention</a> on the occasion of #ESCCongress 2024

Significant work from the #EAPCI Training &amp; Certification Committee and collaborators.

bit.ly/3XowWGh
Giulio Stefanini (@ggstefanini) 's Twitter Profile Photo

Is this the conclusive evidence for #ticagrelor monotherapy in #ACS ? thelancet.com/journals/lance… Comment on the SIDNEY-4: a patient-level analysis of 6 RCTs including >24000 patients by Marco Valgimigli Presented today at #ESCCongress and published in The Lancet Angelo Oliva MD European Society of Cardiology

Carlos Collet MD PhD (@colletcarlos) 's Twitter Profile Photo

#ESC2024 European Society of Cardiology FAME 2: 10-year follow-up 🏪 PCI is 25% more likely to lead to better outcomes than medical therapy alone 🔑 48% of patients were tied. Nearly half the time, it won't make a big difference which one you choose. PCRonline 🫀 CoreAalst OLV HartcentrumAalst Optima Education

#ESC2024 <a href="/escardio/">European Society of Cardiology</a> FAME 2: 10-year follow-up 

🏪 PCI is 25% more likely to lead to better outcomes than medical therapy alone

🔑 48% of patients were tied. Nearly half the time, it won't make a big difference which one you choose.

<a href="/PCRonline/">PCRonline 🫀</a>  <a href="/CoreAalst/">CoreAalst</a> <a href="/CardioAalst/">OLV HartcentrumAalst</a> <a href="/OptimaCTO/">Optima Education</a>